Todd Bazemore, CHIEF OPERATING OFFICER at Kala Pharmaceuticals, Inc. (KALA), sold 12,544 shares at $1.80 ($23K) on 2021-10-26, disclosed to the SEC on 2021-10-28.
Scheduled sale ($23k) by CHIEF OPERATING OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| KALA | SELL | 2025-06-04 | $13K | — | Filing → |
| KALA | SELL | 2025-01-07 | $15K | — | Filing → |
| KALA | SELL | 2024-06-27 | $22K | — | Filing → |